P617-0608 Screening compound: 2-{4-[(6-isopropyl-5-oxo-5,6-dihydropyrido[2,3-b][1,5]benzothiazepin-9-yl)carbonyl]piperazino}ethyl cyanide

P617-0608 Screening compound: 2-{4-[(6-isopropyl-5-oxo-5,6-dihydropyrido[2,3-b][1,5]benzothiazepin-9-yl)carbonyl]piperazino}ethyl cyanide
P617-0608 Screening compound: 2-{4-[(6-isopropyl-5-oxo-5,6-dihydropyrido[2,3-b][1,5]benzothiazepin-9-yl)carbonyl]piperazino}ethyl cyanide alternative view

Chemical Structure Depiction of ChemDiv screening compound P617-0608
2-{4-[(6-isopropyl-5-oxo-5,6-dihydropyrido[2,3-b][1,5]benzothiazepin-9-yl)carbonyl]piperazino}ethyl cyanide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P617-0608

Molecular Formula

C23H25N5O2S (C23 H25 N5 O2 S)

Compound Name

2-{4-[(6-isopropyl-5-oxo-5,6-dihydropyrido[2,3-b][1,5]benzothiazepin-9-yl)carbonyl]piperazino}ethyl cyanide

IUPAC name

3-{4-[9-oxo-10-(propan-2-yl)-2-thia-410-diazatricyclo[9.4.0.0^{38}]pentadeca-1(15)3(8)461113-hexaene-14-carbonyl]piperazin-1-yl}propanenitrile

SMILES

CC(C)N(c(ccc(C(N1CCN(CCC#N)CC1)=O)c1)c1Sc1ncccc11)C1=O

InChI

InChI=1S/C23H25N5O2S/c1-16(2)28-19-7-6-17(22(29)27-13-11-26(12-14-27)10-4-8-24)15-20(19)31-21-18(23(28)30)5-3-9-25-21/h3,5-7,9,15-16H,4,10-14H2,1-2H3

InChI Key

CGKRUKTXJYHWBJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29022214

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

435.55

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.666

Distribution Coefficient, logD

1.666

Water Solubility, LogSw

-2.44

Polar Surface Area

64.376

Acid Dissociation Constant (pKa)

22.02

Base Dissociation Constant (pKb)

4.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

39.10

P617-0608 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-infective Library (19449 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with P617-0608 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P617-0608?
Check Price and Availability of P617-0608, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P617-0608 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P617-0608
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P617-0608
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P617-0608 available by request